Skip to content

MIRA - MIRA PHARMACEUTICALS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

MIRA Pharmaceuticals, Inc. Common Stock

MIRA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MIRAMIRA Pharmaceuticals, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.45
52-wk low: $0.60
Prev close: $1.56
Mkt cap: $32.4M
Beta: 1.55
P/B: 4.1x

Smart money

6 funds hold a position.

Real smart money

Funds holding this stock

6 holders

Combined position$370K

TS
Two Sigma
Q4 2025 13F
$41K
position
AQ
AQR
Q4 2025 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $32M

Valuation

P/B4.12

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MIRA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Market cap: $32.36M
Beta: 1.55

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-217.1%

$33K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$18K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for MIRA

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-217.1%

ROA-129.6%

Growth

Beta1.55